Who owns PRVB - PROVENTION BIO INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

PROVENTION BIO INC - COM (PRVB) Institutional Ownership

Q: What is CUSIP 74374N102?

CUSIP 74374N102 is the security identifier used in SEC filing datasets for PRVB - PROVENTION BIO INC - COM.

CUSIP: 74374N102

13F Institutional Holders and Ownership History from Q3 2018 to Q3 2023

Type / Class: Equity / COM
Symbol: PRVB

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 74374N102?
CUSIP 74374N102 identifies PRVB - PROVENTION BIO INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 74374N102:

Q3 2023 (0 holders) Q2 2023 (1 holder) Q1 2023 (180 holders) Q4 2022 (132 holders) Q3 2022 (110 holders) Q2 2022 (109 holders) Q1 2022 (108 holders) Q4 2021 (104 holders) Q3 2021 (110 holders) Q2 2021 (122 holders)

Institutional Holders of PROVENTION BIO INC - COM (PRVB) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2023 Q3	0	$0	-$2,803,407				0
2023 Q2	116,324	$2,803,407	-$1,458,488,725	$0	$0	$24.10	1
2023 Q1	60,830,767	$1,466,084,773	+$424,074,602	$21,139,250	$15,784,020	$24.10	180
2022 Q4	45,190,066	$477,649,138	+$45,180,377	$2,069,606	$10,210,620	$10.57	132
2022 Q3	41,595,471	$187,175,644	+$74,691,072	$598,000	$1,702,000	$4.50	110
2022 Q2	24,981,743	$99,923,808	+$2,841,504	$327,000	$1,353,000	$4.00	109
2022 Q1	24,173,388	$176,972,484	+$5,260,421	$877,000	$4,491,000	$7.32	108
2021 Q4	23,673,488	$133,041,206	+$7,264,462	$1,192,000	$2,733,000	$5.62	104
2021 Q3	22,266,008	$142,615,278	-$14,513,955	$1,574,000	$2,197,000	$6.40	110
2021 Q2	23,339,997	$196,732,944	-$5,369,483	$5,373,000	$4,304,820	$8.43	122
2021 Q1	23,757,344	$249,316,670	+$9,152,708	$2,045,000	$2,927,000	$10.49	119
2020 Q4	22,323,982	$378,173,718	+$4,367,912	$2,005,000	$795,000	$16.94	106
2020 Q3	22,271,540	$285,747,357	+$16,894,756	$1,221,000	$3,763,000	$12.83	100
2020 Q2	20,852,138	$294,226,104	+$150,501,431	$1,666,000	$7,535,000	$14.11	105
2020 Q1	10,444,701	$96,090,000	+$14,014,067	$591,000	$908,000	$9.20	63
2019 Q4	8,796,802	$131,071,950	+$33,949,985	$1,404,000	$1,600,000	$14.90	58
2019 Q3	6,162,796	$42,196,000	+$25,356,401	$336,000	$96,000	$6.82	48
2019 Q2	2,206,439	$26,695,298	+$19,700,248			$12.10	28
2019 Q1	662,048	$1,522,000	+$57,405			$2.29	10
2018 Q4	637,957	$1,128,000	-$580,204			$1.76	9
2018 Q3	851,412	$3,415,000	+$3,415,000			$4.01	9